AB141575
MW 360 Da, Purity >97%. Selective Bruton's tyrosine kinase (BTK) inhibitor (IC50 = 2.5 μM). Also inhibits polio-like kinase (Plk1) (IC50 = 37.36 μM). Does not effect EGF receptor, insulin recptor, JAK-1 JAK-2, JAK-3, SYK or HCK (IC50 values are all >300 μM). Anticancer and antileukemic agent. Active in vivo.
1 Images
- Chemical Structure
Lab
Chemical Structure - LFM-A13, BTK inhibitor (AB141575)
2D chemical structure image of ab141575, LFM-A13, BTK inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com